Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS)

Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized by the presence of confirmed antiphospholipid antibodies (aPL) positive testing with thrombotic events potentially occurring at any level of the vascular bed [1] with a negative impact on the quality of life (QoL) [2].